New Noncovalent Inhibitors of Penicillin-Binding Proteins from Penicillin-Resistant Bacteria

BACKGROUND: Penicillin-binding proteins (PBPs) are well known and validated targets for antibacterial therapy. The most important clinically used inhibitors of PBPs β-lactams inhibit transpeptidase activity of PBPs by forming a covalent penicilloyl-enzyme complex that blocks the normal transpeptidat...

Descripción completa

Detalles Bibliográficos
Autores principales: Turk, Samo, Verlaine, Olivier, Gerards, Thomas, Živec, Matej, Humljan, Jan, Sosič, Izidor, Amoroso, Ana, Zervosen, Astrid, Luxen, André, Joris, Bernard, Gobec, Stanislav
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090393/
https://www.ncbi.nlm.nih.gov/pubmed/21573060
http://dx.doi.org/10.1371/journal.pone.0019418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090393/
https://www.ncbi.nlm.nih.gov/pubmed/21573060
http://dx.doi.org/10.1371/journal.pone.0019418

Ejemplares similares